Perspective Therapeutics Inc.
CATX | AMEX
$2.90
-$0.07 (-2.36%)
Sep 22, 2026, 1:43 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Jun 29, 2022 | FY 2020 Jun 29, 2021 |
|---|---|---|---|---|---|---|
PE Ratio | -1.96 | -2.59 | -4.73 | -9.15 | -23.77 | -137.35 |
PEG Ratio | -0.14 | -0.06 | -0.02 | -0.08 | -0.19 | -6.85 |
PS Ratio | n/a | 141.35 | 153.92 | 19.09 | 15.72 | 43.58 |
PB Ratio | 0.98 | 0.71 | 2.94 | 2.48 | 2.63 | 34.30 |
P/FCF Ratio | -2.13 | -2.83 | -5.81 | -12.69 | -21.27 | -136.16 |
P/OCF Ratio | -2.46 | -11.23 | -5.98 | -13.04 | -22 | -154.44 |
OCF/S Ratio | n/a | -1.26K | -2.57K | -146.41 | -71.42 | -28.22 |
Debt / Equity Ratio | 0.02 | 0.01 | 0.03 | 0.01 | 0.01 | 0.07 |
Quick Ratio | 5.17 | 12.68 | 1.07 | 19.36 | 33.89 | 8.71 |
Current Ratio | 5.17 | 12.68 | 1.07 | 19.89 | 34.47 | 9.21 |
Asset Turnover | n/a | 0 | 0.01 | 0.12 | 0.16 | 0.65 |
Interest Coverage | -302.03 | -217.90 | -487.39 | n/a | -62.11 | n/a |
Return on Equity | -49.81% | -27.27% | -61.86% | -26.85% | -11.11% | -24.96% |
Return on Assets | -38.63% | -23.24% | -47.51% | -25.25% | -10.64% | -20.55% |
Return on Invested Capital | -47.16% | 3.15% | -46.45% | -28.59% | -11.07% | -22.43% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | 0% |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | -0.28% |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | -0.25% |
Gross Profit Margin | n/a | -58.60% | 100% | 23% | 42.76% | 50.94% |
Net Profit Margin | n/a | -5.45K% | -3.24K% | -206.50% | -66.26% | -31.71% |
Pretax Profit Margin | n/a | -5.6K% | -2.8K% | -206.50% | -67.36% | -33.69% |
Operating Profit Margin | n/a | 719.33% | -2.86K% | -213.71% | -68.47% | -34.19% |
FCF Margin | n/a | -5K% | -2.65K% | -150.38% | -73.89% | -32.01% |
EBITDA Margin | n/a | 719.33% | -2.79K% | -208.87% | -68.47% | -34.10% |
Add to Watchlist
Select watchlists to add or remove CATX